Abstract
Brazilian mucosal leshmaniasis is briefly reviewed, emphasis being given to recent advances clinical management. Patients continue to occupy much hospital bed space and in some cases are notoriously difficult to treat. Indefinite follow up is recommended. Many aspects of the aetiology remain mysterious although Leishmania (Viannia) braziliensis is the most common organism isolated. Perspectives for a more effective treatment, oral and cheap, are still remote.
Subject
Infectious Diseases,Microbiology (medical),Parasitology
Reference29 articles.
1. Chemotherapy for leishmaniasis: Biochemical mechanisms, clinical efficacy, and future strategies;Berman JD;Reviews of Infectious Disease,1988
2. The Leishmaniases in Biology and Medicine;Bryceson ADM.,1987
3. Determining the climatic limitations of a children's cancer common in Africa;Burkitt D;British Medical Journal,1962
4. Leishmaniose de la muqueuse rhino- bucca-pharyngée;Carini A;Bulletin de la Societé Pathologique Exotique,1911
5. Treatment of visceral in Kenya by aminosidine alone or combined with sodium stibogluconate;Chunge CN;Transactions of the Royal Society of Tropical Medicine and Hygiene,1990
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献